Press Releases

Updates arrive automatically.

• Update on the UK Competition and Markets Authority’s review of the AkzoNobel-Axalta merger

  

  PR03:07:49·14m·Consumer Discretionary

  Update on the UK Competition and Markets Authority’s review of the AkzoNobel-Axalta merger

  Akzo Nobel N.V. (AKZA; AKZOY) ("AkzoNobel") and Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta") are considering the UK Competition and Markets Authority’s ("CMA") Phase 1 decision regarding their proposed merger. The CMA’s assessment identifies competition concerns solely relating to the supply of vehicle refinish ("VR") coatings in the UK. AkzoNobel and Axalta aim to address this with the same remedy proposal as included in the decision by the European Commission. AkzoNobel and Axalta have already agreed with the European Commission on a targeted package of undertakings involving the divestment of AkzoNobel’s European VR co

  $AXTA
• Armada and Johnson Controls Launch Galleon Forge Two in Dublin, Bringing Sovereign AI Infrastructure Production to Europe

  

  PR03:00:00·22m·Industrials

  Armada and Johnson Controls Launch Galleon Forge Two in Dublin, Bringing Sovereign AI Infrastructure Production to Europe

  Galleon Forge Two, the second Johnson Controls manufacturing facility supporting Armada's Leviathan, is now in continuous production in Ireland. Sovereign AI infrastructure is now being built in Europe by a European workforce for customers in Europe and beyond. Armada's Galleon Forge operations establish a repeatable manufacturing model that any nation or region can anchor within its own borders. Armada and Johnson Controls are targeting at least 500 MW of capacity in 2027, including the first

  $JCI
• Clarivate's IPOne Connects Trusted Patent, Trademark and Litigation Intelligence to Claude

  

  PR03:00:00·22m·TechnologyPenny stock

  Clarivate's IPOne Connects Trusted Patent, Trademark and Litigation Intelligence to Claude

  New Derwent patent and Darts-ip litigation connections give IP professionals access to curated patent and litigation intelligence alongside

  $CLVT
• GXO and ASOS Extend Strategic Partnership to 2034

  

  PR03:00:00·22m·Consumer Discretionary

  GXO and ASOS Extend Strategic Partnership to 2034

  GXO extends longstanding collaboration to support ASOS' growth and deliver exceptional customer experiences

  $GXO
• Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London

  

  PR02:00:00·1h·Health Care

  Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London

  Leiden, the Netherlands, November 11, 2026: Pharming (NASDAQ:PHAR) today announced its participation in the 2026 Jefferies Global Healthcare Conference in London, United Kingdom, on November 16-19, 2026. Leverne Marsh, Interim Co-CEO & Chief Commercial Officer, and Kenneth Lynard, Interim Co-CEO & Chief Financial Officer, and Michael Levitan, VP Investor Relations and Capital Markets, will participate in a fireside chat Q&A session on Wednesday, November 18 at 9:30 a.m. GMT (10:30 a.m. CET / 4:30 a.m. EST). A live webcast and replay of the presentation will be made available in the "Events and presentations" and "Our news" sections of Pharming’s website. For more information about this co

  $PHAR
• Cadeler Secures Exclusive Agreement for a Full-Scope Offshore Wind Project

  

  PR02:00:00·1h·Consumer Discretionary

  Cadeler Secures Exclusive Agreement for a Full-Scope Offshore Wind Project

  Cadeler today announces that it has signed an exclusivity agreement with an undisclosed client for wind turbine and foundation installation at a large-scale offshore wind farm in the UK. The installation campaign is expected to commence around 2030, with the foundations campaign to be executed using an A-Class vessel and an O-Class vessel, and the wind turbines to be installed by a P-Class vessel. This agreement reflects the importance of securing installation capacity early in the development of large-scale offshore wind projects. Mikkel Gleerup, CEO of Cadeler, comments: "We are very pleased to announce this significant project, which is another important endorsement of the capabili

  $CDLR
• Hafnia’s Q3 2026 Financial Results Presentation to Be Held on 18 November 2026

  

  PR01:42:00·1h·Consumer Discretionary

  Hafnia’s Q3 2026 Financial Results Presentation to Be Held on 18 November 2026

  Hafnia Limited ("Hafnia", the "Company", OSE ticker code: "HAFNI", NYSE ticker code "HAFN") will release its Q3 2026 results at approximately 07:30 CET on the 18th of November 2026. In connection with this release, Hafnia will hold an online investor presentation with Søren Steenberg Jensen (CEO), Perry van Echtelt (CFO), Søren Skibdal Winther (EVP, Commercial), and Thomas Andersen (SVP, Investor Relations, Research and Performance). The details are as follows: Date: Wednesday, 18 November 2026 Location Local Time Oslo, Norway 14:30 CET New York, U.S.A 08:30 EST Singapore 21:30 SGT The financial results presentations will be ava

  $HAFN
• Flex LNG - Third Quarter 2026 Earnings Release

  

  PR01:38:00·1h·Consumer Discretionary

  Flex LNG - Third Quarter 2026 Earnings Release

  Flex LNG Ltd. ("Flex LNG" or the "Company") today announced its unaudited financial results for the quarter ended September 30, 2026. Highlights:Vessel operating revenues of $97.4 million for the third quarter 2026, compared to 106.8 million for the second quarter 2026. Net income of $42.8 million and basic earnings per share of $0.79 for the third quarter 2026, compared to net income of $44.9 million and basic earnings per share of $0.83 for the second quarter 2026. Average Time Charter Equivalent ("TCE") rate of $78,875 per day for the third quarter 2026, compared to $86,119 per day for the second quarter 2026. Adjusted EBITDA of $72.1 million

  $FLNG
• Flex LNG - Third Quarter 2026 Presentation

  

  PR01:23:00·1h·Consumer Discretionary

  Flex LNG - Third Quarter 2026 Presentation

  Please find enclosed the presentation of Flex LNG Ltd.'s third quarter 2026 results which will be presented in a live video webcast today at 15:00 CET (09:00 a.m. EST). In order to watch the webcast, use the following link:Link to register and watch webcast A Q&A session will be held after the webcast. Information on how to submit questions will be given at the beginning of the session. The presentation can also be accessed on our website www.flexlng.com For further information, please contact:Mr. Knut Traaholt, Chief Financial Officer of Flex LNG Management ASTelephone: +47 23 11 40 00Email: ir@flexlng.com This information was brought to you

  $FLNG
• Innate Pharma to Host In-Person and Virtual Event on IPH4502 on November 18, 2026

  

  PR01:00:00·2h·Health CarePenny stock

  Innate Pharma to Host In-Person and Virtual Event on IPH4502 on November 18, 2026

  Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that it will host an event focused on IPH4502, its proprietary Nectin-4 ADC. The event will be held in person and virtually on Wednesday, November 18, 2026 at 11:00 AM ET / 4:00 PM GMT, in London, at the IET London, Savoy Place. Professor Yohann Loriot, M.D., Ph.D. (Gustave Roussy) will join company management to discuss Phase 1 clinical data from the IPH4502 dose-escalation study being presented at the 2026 EORTC-NCI-AACR (ENA) Symposium. The event will include a review of the Phase 1 study's safety, pharmacokinetic and antitumor activity findings, along with a discussion of the cur

  $IPHA
• Western Union Announces Termination of Agreement to Acquire Intermex

  

  

  PR23:45:00·3h·Consumer Discretionary

  Western Union Announces Termination of Agreement to Acquire Intermex

  The Western Union Company ("Western Union") (NYSE:WU) today announced that it has delivered a notice of termination of its agreement to acquire International Money Express, Inc. ("Intermex") (NASDAQ:IMXI). Since entering into the Merger Agreement, Western Union has worked diligently with Intermex and the relevant regulatory authorities to obtain the approvals necessary to complete the transaction. Despite these efforts, the parties were unable to obtain an acceptable approval. Instead, on the evening of November 10, 2026, California’s Department of Financial Protection & Innovation (DFPI) delivered unacceptable final Conditions of Approval that would have required material changes to West

  $WU$IMXI
• Sands China Performing Arts Programme Presents: 'Macau Band Directors Association 30th Anniversary Concert'

  

  PR23:19:00·4h·Consumer Discretionary

  Sands China Performing Arts Programme Presents: 'Macau Band Directors Association 30th Anniversary Concert'

  550 young Macao SAR and French musicians take the stage in a spectacular showcase

  $LVS
• Dingdong to Report Third Quarter 2026 Financial Results on November 12, 2026

  

  PR23:00:00·4h·Consumer DiscretionaryPenny stock

  Dingdong to Report Third Quarter 2026 Financial Results on November 12, 2026

  Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, with advanced supply chain capabilities, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2026, before U.S. markets open on November 12, 2026. About Dingdong (Cayman) Limited Dingdong is the leading fresh grocery e-commerce company in mainland China, with sustainable long-term growth. The Company directly provides users and households with fresh groceries, prepared food, and other food products through delivering a convenient and excellent shopping experience supported by a

  $DDL
• Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

  

  PR22:39:49·4h·Health CareOfferingPenny stock

  Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

  Neuronetics, Inc. (NASDAQ:STIM) (the "Company") today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of 18,750,000 shares of common stock at a public offering price of $1.60 per share. The gross proceeds to the Company from this offering are expected to be approximately $30 million, before deducting underwriting discounts and commissions and other offering expenses payable by the Company. The Company also granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of common stock at the public offering price per share, less underwriting discounts and

  $STIM
• Gap Inc. Announces Fourth Quarter Dividend

  

  PR21:40:00·5h·Consumer Discretionary

  Gap Inc. Announces Fourth Quarter Dividend

  Gap Inc. (NYSE:GAP) today announced that its board of directors has authorized a fourth quarter fiscal year 2026 dividend of $0.175 per share, payable on or after January 27, 2027, to shareholders of record at the close of business on January 6, 2027. About Gap Inc. Gap Inc., a purpose-driven house of iconic brands, is the largest specialty apparel company in America. Its Old Navy, Gap, Banana Republic, and Athleta brands offer clothing, accessories, and lifestyle products for men, women and children available worldwide through company-operated and franchise stores, and e-commerce sites. Through Encore, its cross-brand membership program, Gap Inc. h

  $GAP
• Prime Medicine Announces Pricing of Public Offering of Common Stock

  

  PR21:40:47·5h·Health CareOfferingPenny stockHigh short interest

  Prime Medicine Announces Pricing of Public Offering of Common Stock

  Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the pricing of an underwritten public offering of 35,714,286 shares of its common stock at a public offering price of $3.50 per share. Prime Medicine has also granted the underwriters a 30-day option to purchase up to an additional 5,357,142 shares of its common stock. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $125.0 million, excluding any exercise of

  $PRME
• ImmunityBio to Participate in UK Investor Conferences During London Life Sciences Week 2026

  

  PR21:31:00·5h·Health CareHigh short interest

  ImmunityBio to Participate in UK Investor Conferences During London Life Sciences Week 2026

  Senior leadership will discuss ImmunityBio’s clinical and commercial priorities at Jefferies Global Healthcare Conference and UBS Global Biopharma Conference in London ImmunityBio, Inc. (NASDAQ:IBRX), a commercial-stage immunotherapy company, today announced members of the senior leadership team will speak at the upcoming Jefferies Global Healthcare Conference and the UBS Global Biopharma Conference, both held in London during Life Sciences Week 2026, November 15-20. "The results from our QUILT-2.005 study bring us closer to our goal of treating bladder cancer earlier in the course of the disease," said Richard Adcock, President and CEO of ImmunityBio. "In London, we look forward to dis

  $IBRX
• Hagerty Announces Pricing of its Upsized Secondary Offering of Class A Common Stock

  

  PR20:53:00·6h·FinanceOffering

  Hagerty Announces Pricing of its Upsized Secondary Offering of Class A Common Stock

  Hagerty, Inc. (NYSE:HGTY) ("Hagerty"), a business that makes it easier and more enjoyable to be a driving enthusiast, announced the pricing of its secondary offering, upsized to 10,000,000 shares of Hagerty's Class A Common Stock, being offered by Hagerty Holding Corp. ("HHC" or the "Selling Stockholder") at a price to the public of $14.85 per share. In connection with the offering, the Selling Stockholder also granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of Hagerty's Class A Common Stock. The offering is expected to close on or about November 12, 2026, subject to the satisfaction of customary cl

  $HGTY
• Public Service Company of New Mexico Declares Preferred Dividend

  

  PR20:51:00·6h·Utilities

  Public Service Company of New Mexico Declares Preferred Dividend

  The Board of Directors of Public Service Company of New Mexico, a subsidiary of TXNM Energy (NYSE:TXNM), declared the regular quarterly dividend of $1.145 per share on the 4.58 percent series of cumulative preferred stock. The preferred stock dividend is payable January 15, 2027, to shareholders of record at the close of business December 31, 2026. Background:TXNM Energy (NYSE:TXNM), an energy holding company based in Albuquerque, New Mexico, delivers energy to more than 800,000 homes and businesses across Texas and New Mexico through its regulated utilities, TNMP and PNM. For mo

  $TXNM
• Better 2.0 Publishes Weekly Scorecard, Week 5: Wholesale Platform Grows to 43 Brokerages as Savings Reach $34.1 Million

  

  PR20:31:00·6h·FinanceHigh short interest

  Better 2.0 Publishes Weekly Scorecard, Week 5: Wholesale Platform Grows to 43 Brokerages as Savings Reach $34.1 Million

  Actions to date expected to deliver $34.1 million in annualized savings toward the approximately $64.2 million target Better Home & Finance Holding Company (NASDAQ:BETR) today released Week 5 of its Better 2.0 weekly scorecard, a public record of the company’s turnaround published every Tuesday. This week, Better expanded its wholesale platform to 43 brokerages, advanced negotiations on approximately $50 million in debt financing tied to the planned sale of Birmingham Bank, and engaged Daversa Partners to lead its CEO search. Better also continued to execute on its cost reduction plan, increasing total realized savings to $34.1 million, well on its path towards its $64.2 million target.

  $BETR